Patents
Patents for C07C 259 - Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups (4,411)
05/2001
05/23/2001EP1101496A1 Therapeutic agents for allergic diseases
05/23/2001EP1100812A2 Resin derivatization method and uses thereof
05/23/2001DE19955476A1 Bis-basische Verbindungen als Tryptase-Inhibitoren, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Bis-basic compounds as tryptase inhibitors, to processes for their preparation and their use as medicaments
05/22/2001US6235790 Hydroxamic-acid derivatives, method of preparing them and their use as fungicides
05/22/2001US6235787 Antiinflammatory agents; rheumatic diseases; bone disorders; skin disorders; multiple sclerosis
05/22/2001US6235753 Tumor necrosis factor; autoimmune diseases; antiallergens
05/16/2001EP1098659A2 Libraries of polyhydroxamates and their analogs
05/15/2001US6232492 Reacting arylhydroxylamine with a ketene
05/09/2001EP1097117A2 Aryl vinyl ether derivatives and their use as herbicides
05/09/2001EP0633776B1 Compounds useful for treating allergic and inflammatory diseases
05/03/2001WO2001030747A1 Hydroxamic acid derivative as inhibitor of the formation of soluble human cd23
05/03/2001CA2389319A1 Hydroxamic acid derivative as inhibitor of the formation of soluble human cd23
05/02/2001EP1095012A1 Novel salts of n-tert-butylhydroxylamine
05/01/2001US6225351 For therapy of asthma, arthritis, and sepsis bronchitis, chronic obstructive airways disease, psoriasis, allergic rhinitis, dermatitis, sepsis, septic shock, cachexia, acquire immuno deficiency syndrome (aids)
05/01/2001US6225349 Hydroximic acid halogenides, method for the production and use thereof
04/2001
04/25/2001EP1093819A2 Compounds and compositions for delivering active agents
04/18/2001EP1091938A2 Antihistaminic piperidine derivatives and intermediates for the preparation thereof
04/18/2001EP1091937A1 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them
04/17/2001US6218389 For therapy and prophylaxis of arthritis, cancer, cardiovascular disorders; skin disorders; ocular disorders; inflammation and gum diseases, multiple sclerosis, cachexia, preventing loosening of prosthetic devices
04/12/2001WO2001025187A2 Benzyl amidoxime derivatives, intermediate products and method for their production and use as fungicides
04/12/2001CA2386513A1 Novel benzyl amidoxime derivatives, intermediate products and method for their production and use as fungicides
04/11/2001EP1090150A1 Mineral collector compositions of fatty hydroxamic acid in admixture with an oil and process of making same
04/11/2001EP1089964A1 Hydrazine derivatives
04/11/2001EP1089963A1 Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release
04/11/2001EP1089958A2 Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and alpha,beta-unsaturated carboxylic acid and aldehyde compounds
04/11/2001CN1291183A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors
04/10/2001US6214883 Benzamidoxime prodrugs as antipneumocystic agents
04/10/2001US6214835 Dihalopropene compounds insecticides containing them as active ingredients, and intermediates for their production
04/04/2001EP1087937A1 Cyclic hydroxamic acids as metalloproteinase inhibitors
04/03/2001US6211240 O-benzyl oxime ether derivatives and their use as pesticides
04/03/2001US6211232 Reaction of benzonitrile with hydroxylamine in the presence of chelation agent
03/2001
03/29/2001WO2001021583A1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient
03/28/2001EP0873305B1 Azinooximethers, processes and intermediate products for manufacturing same, and the uses thereof in combating harmful fungi and pests
03/28/2001EP0850216B1 Hydroximic acid derivatives, a process for preparing the same and their use as pesticides and fungicides
03/28/2001CN1289319A Diterpene derivatives and anti-inflammatory analgesic agents comprising the same
03/27/2001US6207708 For therapy and prophylaxis of autoimmune and/or inflammatory conditions affecting the joints such as arthritis, and inflammatory bowel disease, cardivascular ischemia, diabetes, congestive heart failure, myocarditis, atherosclerosis,
03/22/2001WO2000061134A8 Antimicrobial agents
03/15/2001WO2001018171A2 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
03/15/2001WO2001017982A1 Benzophenones as inhibitors of reverse transcriptase
03/15/2001WO2000051972A8 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
03/15/2001US20010000038 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives
03/15/2001CA2383999A1 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
03/15/2001CA2383782A1 Compounds for the treatment of viral infections
03/14/2001EP1082295A1 Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors
03/14/2001EP0805800B1 Method for preparing (+)compactin and (+)mevinolin analog compounds having a beta-hydroxy-delta-lactone grouping
03/08/2001WO1999039704A8 Antibacterial agents
03/08/2001WO1999019296A8 Aminobutanoic acid derivatives
03/07/2001EP1081132A1 Hydroxamic acid derivatives and medicinal utilization thereof
03/07/2001EP0858446B1 Phenylcarbamates, processes and intermediate products for their preparation and their use as pesticides and fungicides
03/07/2001CN1286681A Cytostatic agents
03/01/2001WO2001014390A2 METABOTROPIC GLUTAMATE RECEPTOR LIGAND DERIVATIVES AS NAALADase INHIBITORS
02/2001
02/28/2001EP1078917A1 Amidino derivatives and drugs containing the same as the active ingredient
02/27/2001US6194451 Prevent release tumor necrosis factor; antiinflammatory agents
02/22/2001WO2000071500A8 Halogen compounds
02/21/2001CN1284942A Matrix metalloprotease inhibitors
02/20/2001US6190685 Antioxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same
02/15/2001WO2001010835A1 Antibacterial agents
02/15/2001WO2000059497A8 Pyrrolidine modulators of chemokine receptor activity
02/14/2001CN1284060A Novel metalloproteinase inhibitors
01/2001
01/31/2001CN1282319A Aminobutanoic acid derivatives
01/31/2001CN1282318A Optically active intermediates for preparation of optically active substituted oximex, hydrazones and olefins useful as neurokinin antagonists
01/30/2001US6180818 Compound providing improved storage stability
01/30/2001US6180787 Process for preparing o-(3-amino-2-hydroxy-propyl)-hydroxymic acid halides
01/25/2001WO2001005748A1 Oligomeric amino acid derivatives useful as nitric oxide synthase inhibitors
01/24/2001CN1281444A Azulene hydroxamic acid derivatives as metalloprotein inhibitors
01/23/2001US6177463 Oxime derivatives and their use as pesticides
01/23/2001US6177459 Substituted heterocyclic compounds and their use as fungicides
01/16/2001US6174887 Amide compounds and use of the same
01/10/2001CN1279674A 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analoguse), their preparation and their use in the treatment of neurological disorders
01/10/2001CN1279673A ((Cyclo) alkyl substituted-.gamma.-aminobutyric acid derivatives (=GABA analogurs), their preparation and their use in the treatment of neurolog disorders
01/10/2001CN1279667A 4(3)-substituted-4(3)-aminonethyl-(thioxo)pyran(thiapyran)or-piperidine derivatives(=gabapendin analogues), their preparation and their use in treatment of neurological disorders
01/10/2001CN1060472C Hydroxamic acid derivatives with tricylic substitution, their preparing methods, medicines containing them and uses thereof
01/09/2001US6172064 Formamides as therapeutic agents
01/03/2001EP1063984A1 Inflammatory cell inhibitors
01/03/2001CN1278789A 9,10-Dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors
01/03/2001CN1278785A Vanadium complexes of monohydroxamates and pharmaceutical compositions comprising them
01/02/2001US6169075 Antitumor agent inhibiting the proliferation of a range of rapidly dividing tumour cells like melanoma and/or lymphoma cells
12/2000
12/27/2000EP1062202A1 Cytostatic agents
12/27/2000EP0821666B1 Derivatives of succinamide and their use as metalloproteinase inhibitors
12/27/2000CN1278245A Malonic acid based matric metalloproteinase inhibitors
12/26/2000US6166254 Method of manufacturing high purity amidoximes from hydroxylamine and nitriles
12/21/2000DE19927602A1 One-part, multiphase color developer concentrate, useful for preparing developer for color photographic material with high silver chloride content, contains hydroxyl-amine or -amide derivative as antioxidant
12/20/2000EP1061068A1 Process for producing benzamidoximes
12/20/2000EP0918748B1 Fungicides
12/13/2000CN1276786A 3-aryl-succinamido-hydroxamic acids, method for producing said acids and medicaments contg. same
12/12/2000US6159983 Method and composition for treatment of inflammatory bowel disease
12/06/2000EP1056710A1 Diterpene derivatives and anti-inflammatory analgesic agents comprising the same
12/06/2000CN1275914A Antioxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same
12/05/2000US6156884 Bifunctional boronic compound complexing reagents and complexes
11/2000
11/30/2000WO2000071500A1 Halogen compounds
11/29/2000EP1054878A1 Azulene hydroxamic acid derivatives as metalloprotein inhibitors
11/29/2000EP1054861A1 Cytostatic agents
11/29/2000EP1054858A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
11/29/2000CN1274721A Prepn. of hydroxamic acid
11/29/2000CN1274711A New intermediate for preparation of anti-histamine piperidine derivatives
11/28/2000US6153793 Deesterification and oxyamination of aminoesters
11/23/2000WO2000069812A1 Novel hydroxamic acid derivatives
11/23/2000DE19922934A1 New 5,5-dihalo- or 4,5,5-trihalo-4-pentenoic acid derivatives, useful as bactericides, fungicides, insecticides, acaricides and nematocides, especially plant fungicides
11/23/2000CA2373439A1 Novel hydroxamic acid derivatives
11/22/2000EP1052984A1 Antibacterial agents
1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ... 45